Mouse Anti-DDAH2 Recombinant Antibody (3E3) (CBMAB-D0446-YC)

Chen, W., Wang, H., Liu, J., & Li, K. (2022). Interference of KLF9 relieved the development of gestational diabetes mellitus by upregulating DDAH2. Bioengineered, 13(1), 395-406.

Li, J., Sun, L., & Li, Y. (2021). Regulation of dimethylarginine dimethylaminohydrolase 2 expression by NF‑κB acetylation. Experimental and Therapeutic Medicine, 21(2), 1-1.

Lin, H. H., Lee, T. S., Lin, S. J., Yeh, Y. C., Lu, T. M., & Hsu, C. P. (2019). DDAH-2 alleviates contrast medium iopromide-induced acute kidney injury through nitric oxide synthase. Clinical Science, 133(23), 2361-2378.

Mannino, G. C., Pezzilli, S., Averta, C., Fuoco, A., Spiga, R., Mancuso, E., ... & Sesti, G. (2019). A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients. Cardiovascular Diabetology, 18(1), 1-9.

Zhu, Z. D., Ye, J. M., Fu, X. M., Wang, X. C., Ye, J. Y., Wu, X. R., ... & Zhang, X. (2019). DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH/ADMA/NOS/NO pathway in rats. International Journal of Molecular Medicine, 43(2), 749-760.

Lambden, S., Tomlinson, J., Piper, S., Gordon, A. C., & Leiper, J. (2018). Evidence for a protective role for the rs805305 single nucleotide polymorphism of dimethylarginine dimethylaminohydrolase 2 (DDAH2) in septic shock through the regulation of DDAH activity. Critical Care, 22(1), 1-9.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols